Weekly intramuscular methotrexate in the treatment of low-risk gestational trophoblastic neoplasia

被引：0
|
作者：
Mitra Mohit
Zahra Sarraf
Gelavizh Sheikhi
Minoo Robati
Amir Vasheghani-Farahani
机构：
[1] Shiraz University of Medical Sciences,Department of Obstetrics and Gynecology
[2] Islamic Azad University,Department of Obstetrics and Gynecology
[3] Medical Sciences Branch of Tehran,Department of Obstetrics and Gynecology
[4] Booali Hospital,undefined
来源：
Archives of Gynecology and Obstetrics | 2009年 / 280卷
关键词：
Gestational trophoblastic neoplasia; Low-risk gestational trophoblastic neoplasia (LRGTN); Single-agent chemotherapy; Methotrexate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：775 / 780
页数：5
相关论文
共 50 条
  • [21] Methotrexate on a 21-Day Cycle for Low-Risk Gestational Trophoblastic Neoplasia
    Diaz, Juan
    Thomas, M. Bijoy
    Paz-Pabon, Charlotte
    Hernandez, Enrique
    JOURNAL OF REPRODUCTIVE MEDICINE, 2012, 57 (9-10) : 411 - 414
  • [22] Low-Risk Gestational Trophoblastic Neoplasia in Manitoba Experience With Alternating Methotrexate and Dactinomycin
    Carlson, Vanessa
    Walters, Leslea
    Lambert, Pascal
    Dean, Erin
    Lotocki, Robert
    Altman, Alon D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (08) : 1448 - 1452
  • [23] Actinomycin D for Methotrexate-Failed Low-Risk Gestational Trophoblastic Neoplasia
    Lurain, John R.
    Chapman-Davis, Eloise
    Hoekstra, Anna V.
    Schink, Julian C.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2012, 57 (7-8) : 283 - 287
  • [24] Differences in Administration of Methotrexate and Impact on Outcome in Low-Risk Gestational Trophoblastic Neoplasia
    Wallin, Emelie
    Niemann, Isa
    Faaborg, Louise
    Fokdal, Lars
    Joneborg, Ulrika
    CANCERS, 2022, 14 (03)
  • [25] Predictive factors associated with resistance to initial methotrexate treatment in women with low-risk gestational trophoblastic neoplasia
    Phianpiset, Rattiya
    Ruengkhachorn, Irene
    Kuljarusnont, Sompop
    Jareemit, Nida
    Udompunturak, Suthipol
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (05) : E495 - E506
  • [26] Comparison of methotrexate, actinomycin D, and etoposide for treating low-risk gestational trophoblastic neoplasia
    Baptista, Angela M.
    Belfort, Paulo
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2012, 119 (01) : 35 - 38
  • [27] Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia
    Lurain, John R.
    Schink, Julian C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (36) : 4349 - +
  • [28] Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity
    Chalouhi, Gihad Elias
    Golfier, Francois
    Soignon, Pauline
    Massardier, Jerome
    Guastalla, Jean-Paul
    Trillet-Lenoir, Veronique
    Schott, Anne-Marie
    Raudrant, Daniel
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 200 (06) : 643.e1 - 643.e6
  • [29] Combined methotrexate-dactinomycin: An effective therapy for low-risk gestational trophoblastic neoplasia
    Eiriksson, Lua
    Wells, Tiffany
    Steed, Helen
    Schepansky, Alexandra
    Capstick, Valerie
    Hoskins, Paul
    Pike, Judith
    Swenerton, Kenneth
    GYNECOLOGIC ONCOLOGY, 2012, 124 (03) : 553 - 557
  • [30] WEEKLY INTRAMUSCULAR METHOTREXATE FOR NONMETASTATIC GESTATIONAL TROPHOBLASTIC DISEASE
    HOMESLEY, HD
    BLESSING, JA
    RETTENMAIER, M
    CAPIZZI, RL
    MAJOR, FJ
    TWIGGS, LB
    OBSTETRICS AND GYNECOLOGY, 1988, 72 (03): : 413 - 418
12345